Session 57 - CROI 2008

Home

Session 57 Poster Abstracts
Factors Impacting Disease Progression
Monday, 1-4 pm
Room: Hall D

295	Identification of an IL-7RA Risk Allele for Rapid Progression to AIDS: Results of a Genomic IL-7/IL-7RA Study in the GRIV Cohort Sophie Limou*^1,2,3, C Coulonges¹, H Do², A Vasilescu², T Labib^1,3, I Gut², J D Lelievre³, Y Levy³, and J F Zagury^1,3 ¹Conservatoire Natl des Arts et Metiers, Paris, France; ²CEA, Evry, France; and ³Hosp Henri Mondor, INSERM U84, Creteil, France
296	CCL3L1 Variable Gene Copy Number Influence on the Susceptibility to HIV-1/AIDS among Estonian Intravenous Drug User Maarja Sadam*, K Huik, R Avi, T Karki, K Ruutel, and I Lutsar Inst of Microbio, Univ of Tartu, Estonia
297	Interferon-gamma Genotype (874T>A) Is Associated with CCR5 Expression in HIV⁺ Patients N Liptrott, B Chandler, S Khoo, D Back, and Andrew Owen* Univ of Liverpool, UK
298	Use of a Dually Inducible Cell Line Reveals Distinct Patterns of CD4 and CCR5 Usage among Laboratory and Primary HIV-1 and SIV Strains Samantha Johnston*¹, M Lobritz², S Nguyen¹, C Garibay¹, B Ank¹, Y Bryson¹, E Arts², T Chou¹, and B Lee¹ ¹Univ of California, Los Angeles, US and ²Case Western Reserve Univ, Cleveland, OH, US
299	Lack of Effect of Short Viremic Episodes in LPS Plasma Levels in Chronically HIV-1-infected Subjects Emmanouil Papasavvas*¹, M Pistilli¹, A Hancock¹, G Reynolds¹, A Mackiewicz¹, C Gallo², J Kostman^2,3, K Mounzer², J Shull², and L Montaner¹ ¹Wistar Inst, Philadelphia, PA, US; ²Philadelphia Field Initiating Group for HIV Trials, PA, US; and ³Univ of Pennsylvania, Philadelphia, US
300	Reduction in the Absolute Number of Myeloid Dendritic Cells and Plasmacytoid Dendritic Cells in HIV Infection Correlates with Disease Progression Meera Singh*, M Thakar, S Suregaonkar, M Ghate, and R Paranjape Natl AIDS Res Inst, Pune, India
301	Role of TLR in HIV-1 Pathogenesis Beda Brichacek*, A Biancotto, Y Kiselyeva, C Vanpouille, A Lisco, J Grivel, and L Margolis NIH, Bethesda, MD, US
304	Micro-RNA of Host and HIV Origin Play a Major Role in the Pathogensis of HIV Infection and Its Control Zvi Bentwich*^1,2, E Meiri², A Levy², O Carmi¹, and Y Shemer¹ ¹Ben Gurion Univ Faculty of Hlth Sci, Beer Sheba, Israel and ²Rosetta Genomics Inc, Rehovot, Israel
305	Chemokine Receptor Gene (CCR5 and CCR2) Haplotypes as Risk Factors for HIV-1 Acquisition and Pathogenesis Rakhi Malhotra*¹, W Song¹, I Brill¹, D Chanda², J Mulenga², S Allen^2,3, E Hunter³, J Tang¹, and R Kaslow¹ ¹Univ of Alabama at Birmingham, US; ²Rwanda-Zambia HIV-1 Res Group, Lusaka; and ³Emory Univ, Atlanta, GA, US
306	Viroverse: A Research Database and Bioinformatics Analysis Framework Brandon Maust*¹, W Deng¹, J StEvenard¹, Z Frazier², M Guerquin¹, G Learn¹, R Samudrala¹, R Bumgarner¹, and J Mullins¹ ¹Univ of Washington, Seattle, US and ²Univ of Southern California, Los Angeles, US
307a	HIV-specific B Cells Are Enriched in a Dysfunctional Memory B Cell Compartment in HIV-infected Viremic Individuals Susan Moir*, J Ho, A Malaspina, W Wang, A DiPoto, M O'Shea, G Roby, J Arthos, T W Chun, and A Fauci NIAID, NIH, Bethesda, MD, US
307b	KIR/HLA Genotypes that Inhibit NK Cell Activation Are Associated with Protection against HIV-1 Disease Progression Wim Jennes*¹, S Verheyden², C Demanet², O Tossou³, B Vuylsteke¹, and L Kestens¹ ¹Inst of Tropical Med, Antwerp, Belgium; ²Univ Hosp Brussels, Belgium; and ³Project RETRO-CI, Abidjan, Côte d`Ivoire
307c	Severe Primary Sexually Transmitted HIV Infection Due to Dual-tropic HIV-1 J Dalmau¹, M Puertas¹, M Azuara², A Mariño³, N Izquierdo-Useros¹, M Buzón¹, R Paredes¹, C Rodrigo², Bonaventura Clotet*^1,2, and J Martinez-Picado^1,4 ¹Fndn irsiCaixa, Badalona, Spain; ²Hosp Univ Germans Trias i Pujol, Badalona, Spain; ³Hosp Arquitecto Marcide, El Ferrol, Spain; and ⁴ICREA, Barcelona, Spain